Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 3Other 2Lymphoid 2Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 4399Urinary Bladder Neoplasms 1078Carcinoma, Renal Cell 1041Kidney Neoplasms 567Breast Neoplasms 453Neoplasms 403Carcinoma, Transitional Cell 299Neoplasm Metastasis 250Lung Neoplasms 242Testicular Neoplasms 202Melanoma 195Colorectal Neoplasms 193Ovarian Neoplasms 163Carcinoma, Non-Small-Cell Lung 150Sarcoma 135Non-Muscle Invasive Bladder Neoplasms 135Pancreatic Neoplasms 124Colonic Neoplasms 121Head and Neck Neoplasms 116Uterine Cervical Neoplasms 115Wilms Tumor 108Recurrence 106Motor Activity 100Stomach Neoplasms 89Urologic Neoplasms 88Neuroblastoma 88Disease 85Multiple Myeloma 83Carcinoma, Hepatocellular 79Adenocarcinoma 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Peripheral Arterial Disease × Genitourinary × Clear all
NCT03987633 2025-03-10

EMPOWER

Future Genetics Limited

Recruiting
200,000 enrolled
GenitourinaryOtherThoracic

Ischemic Stroke, Arthritis, Rheumatoid, Asthma, Atrial Fibrillation, Mental Disorders, Cardiovascular Diseases, Coronary Disease, Dementia, Depression, Diabetes Mellitus, Epilepsy, Heart Failure, Hypertension, Lung Neoplasms, Neoplasms, Obesity, Prostatic Neoplasms, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡